Banxia-Xiexin-Decoction-based sequential therapy for Helicobacter pylori infection eradication: a real-world study

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine0 个研究点开始时间: 待定最近更新: 2023年2月20日

试验速览

暂无简介。

•(1) Meet the diagnostic criteria;
•(2) Aged 18-70 years;
•(3) Actively cooperated with the treatment and willing to accept the follow-up visit as the observation objects;
•(4) Did not take any drugs related to the treatment effect of this study within 4 weeks before the start of the observation.

•(1) Patients who had HP eradication treatment within 6 months;
•(2) patients with gastrointestinal ulcer indicated by endoscopy;
•(3) patients with liver and kidney dysfunction, severe cardiovascular and cerebrovascular diseases, and malignant tumor diseases;
•(4) those who were definitely diagnosed with mental disorders, speech and behavior disorders;
•(5) pregnant or lactating women;
•(6) patients with drug allergy history;
•(7) patients with liver and kidney dysfunction and severe cardiovascular and cerebrovascular diseases and malignant tumor diseases Participants or participants in other drug trials in the past 3 months.

发起方

Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine